Search - tctmd.com

Displaying 561 - 580 of 8219

Sort: Relevancy | Date

Presentation TCT 2016

Processes for Individualized TAVR Patient Selection and Clinical Pathways

Presenter: Marian C. Hawkey, Sandra Lauck

October 30, 2016

Presentation TCT 2016

ACS Case Presentation: Where Pharmacotherapy Failed

Presenter: C. Michael Gibson, Daniel I. Simon, Gennaro Giustino

October 30, 2016

Presentation TCT 2016

Limitations of Pharmacotherapy Clinical Trial Design

Presenter: C. Michael Gibson, Daniel I. Simon, Sanjay Kaul

October 30, 2016

Presentation TCT 2016

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With STEMI

Presenter: C. Michael Gibson, Daniel I. Simon, Sunil V. Rao

October 30, 2016

Presentation TCT 2016

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With NSTE-ACS

Presenter: C. Michael Gibson, Daniel I. Simon, Glenn N. Levine

October 30, 2016

Presentation TCT 2016

How to Interpret Hemodynamic and Echo Data for Transcatheter Mitral Valve Repair Clinical Decision-Making and Procedural Guidance

Presenter: Jeff Davis, James B. Hermiller Jr.

October 29, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2016

Caitlin E. Cox

October 29, 2016

Presentation TCT 2016

How to Interpret Hemodynamic, CT, and Echo Data for TAVR Clinical Decision-making and Procedural Guidance

Presenter: Thomas H. Maloney, Paul D. Mahoney

October 29, 2016

News Conference News TCT 2016

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Michael O'Riordan

October 29, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

Presentation Stanford Coronary Physiology Conference 2016

Absolute Coronary Flow and Microvascular Resistance First Clinical Studies

Presenter: Bernard De Bruyne

October 28, 2016

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

News Daily News

La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes

Yael L. Maxwell

October 28, 2016

News Daily News

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Yael L. Maxwell

October 28, 2016

News Daily News

FH Screening Started at Time of Childhood Immunization Feasible and Effective

Michael O'Riordan

October 28, 2016

News Daily News

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Yael L. Maxwell

October 28, 2016

News Daily News

Hybrid Algorithm for CTO PCI Delivers High Success Rates, Registry Affirms

Todd Neale

October 28, 2016

News Industry News

Academic Research Organization HCRI Changes Name to The Baim Institute for Clinical Research

October 27, 2016

News Industry News

Corindus Vascular Robotics Receives FDA Clearance for Next Generation Robotic System

October 27, 2016

News Daily News

Cardiac Rehab: No Impact on Quality of Life for Acute MI Patients?

Yael L. Maxwell

October 27, 2016

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2016

Ankur Kalra

October 27, 2016

Advertisement

Processes for Individualized TAVR Patient Selection and Clinical Pathways

ACS Case Presentation: Where Pharmacotherapy Failed

Limitations of Pharmacotherapy Clinical Trial Design

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With STEMI

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With NSTE-ACS

How to Interpret Hemodynamic and Echo Data for Transcatheter Mitral Valve Repair Clinical Decision-Making and Procedural Guidance

TCTMD’s Top 10 Most Popular Stories for October 2016

How to Interpret Hemodynamic, CT, and Echo Data for TAVR Clinical Decision-making and Procedural Guidance

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Absolute Coronary Flow and Microvascular Resistance First Clinical Studies

La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

FH Screening Started at Time of Childhood Immunization Feasible and Effective

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Hybrid Algorithm for CTO PCI Delivers High Success Rates, Registry Affirms

Academic Research Organization HCRI Changes Name to The Baim Institute for Clinical Research

Corindus Vascular Robotics Receives FDA Clearance for Next Generation Robotic System

Cardiac Rehab: No Impact on Quality of Life for Acute MI Patients?

My Picks for Fellows Attending TCT 2016

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content